bloodthinners

Using lucrative strategy, Johnson & Johnson seeks fifth use of anticlotting drug

Using lucrative strategy, Johnson & Johnson seeks fifth use of anticlotting drug

Yahoo/AP

J&J Drug Treats Lung Clots With Less Bleeding, Study Finds

J&J Drug Treats Lung Clots With Less Bleeding, Study Finds

Bloomberg

Boehringer’s Pradaxa Wins U.K. Agency’s Backing in Stroke

Boehringer’s Pradaxa Wins U.K. Agency’s Backing in Stroke

Bloomberg

Death magnifies Pradaxa hemorrhage concerns

Death magnifies Pradaxa hemorrhage concerns

Reuters

Pfizer and Bristol-Myers’ Blood Thinner Delayed by FDA

Pfizer and Bristol-Myers’ Blood Thinner Delayed by FDA

Bloomberg

Will FDA Delay Approving The Eliquis Bloodthinner?

Will FDA Delay Approving The Eliquis Bloodthinner?

Pharmalot

Bayer wins EU approval for stroke drug Xarelto

Bayer wins EU approval for stroke drug Xarelto

Reuters

Sanofi spikes authorized Lovenox generic

Sanofi spikes authorized Lovenox generic

Fierce Pharma

EU backs Boehringer's Pradaxa despite 256 deaths

EU backs Boehringer's Pradaxa despite 256 deaths

Reuters

High Plavix doses overcome genetic barrier-study

High Plavix doses overcome genetic barrier-study

Reuters